GREY:ISOLF - Post by User
Post by
Balthuson Oct 04, 2017 7:34am
121 Views
Post# 26773998
News: Approval process for Chilean market
News: Approval process for Chilean market https://thecse.com/sites/default/files/Isodiol_NR_-_Oct_4_2017.pdf
ISODIOL INTERNATIONAL INC. COMMENCES APPROVAL PROCESS TO BRING ISODIOL TO CHILEAN MARKET
4, 2017 - Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, is pleased to announce that the Company has officially initiated the approval process to begin exporting its flagship product, Isoderm to Chile.
Marcos Agramont, CEO of Isodiol, stated, “Earlier this year, Chile became the first country in Latin America to allow the sale of cannabis-based medicines in pharmacies. This gives the Company a unique advantage considering our distribution partner, FarmaUSA, has existing distribution channels that we will be able to immediately utilize. We are thrilled by the possibility of expanding Isodiol’s Latin American market initiative to provide Chilean patients with high quality CBD products. As the global market evolves, Isodiol has every intention to be at the forefront of product development and innovation.”
Chile legalized the use of medicinal marijuana in 2015 and is among a number of Latin American countries gradually loosening laws prohibiting the cultivation, distribution, and consumption of cannabis. Isodiol is one of the first companies to register a CBD product with the Chilean Health Department. ....etc at https://thecse.com/sites/default/files/Isodiol_NR_-_Oct_4_2017.pdf